Vetanova

Vetanova FCF/Debt

Delisted

The Free Cash Flow to Debt Ratio of Vetanova (VTNA) as of Nov 19, 2026 is -293.55 %. In the previous year, Free Cash Flow to Debt Ratio was -71.43 % — a change of 310.97% (lower).

FCF/Debt

-293.55 %

YoY

310.97%

Last updated:

Free Cash Flow to Debt Ratio of Vetanova is 2021 -293.55 % . Free Cash Flow to Debt Ratio of Vetanova was 2020 -71.43 % . It decreases by 310.97% lower compared to the previous year.

The Vetanova FCF/Debt history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

FCF/Debt
Date
FCF/Debt
Jan 1, 2014
-71.43 USD
Jan 1, 2021
-293.55 USD
The Vetanova FCF/Debt history
YEARFCF/DebtYoY
-293.55 %+310.97%
-71.43 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Vetanova Stock analysis

What does Vetanova do? Vetanova Inc is a company that specializes in the production of veterinary medicines and has its roots in the animal health industry. It was founded in 2005 by a team of experienced veterinarians with the aim of improving the treatment of pets and livestock through the development of innovative products. Vetanova's business model is based on the manufacturing and marketing of veterinary medicines, as well as the sale of pet food and care products. The company's different divisions include both the development and production of prescription drugs and over-the-counter products, which are sold in specialty stores and online shops. Vetanova has specialized particularly in the development of medicines against infections, parasites, and inflammation. The company relies on a combination of traditional and modern manufacturing processes to bring high-quality products to the market. In addition to manufacturing medicines, Vetanova also offers a variety of products for the care and nutrition of pets. These include dietary supplements, pet care products, and specialized pet food tailored to their needs. As a company dedicated to the quality of its products and the health of animals, Vetanova works closely with veterinarians and breeders to ensure that its products meet high standards. In this regard, Vetanova also strives to intensify collaboration with scientific institutions to improve and further develop the effectiveness of its products. Animal welfare is also an important factor for Vetanova. The company advocates for the protection and well-being of animals and supports projects that help animals in need. In summary, Vetanova is a successful and renowned company that has specialized in the development and production of veterinary medicines since 2005. The company offers a wide range of products, including both prescription and over-the-counter products, targeting both pets and livestock. Vetanova is dedicated to the health of animals and focuses on collaborating with veterinarians and breeders to improve the effectiveness and quality of its products. Animal welfare and sustainability are other important aspects emphasized by Vetanova. Vetanova is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vetanova stock

Free Cash Flow to Debt Ratio of Vetanova is -293.55 % in 2021.

Free Cash Flow to Debt Ratio of Vetanova changed from -71.43 % to -293.55 %, representing a 310.97% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Free Cash Flow to Debt Ratio Vetanova since 2006 – with annual values, charts, and detailed analysis.

FCF/Debt measures the percentage of total debt that could be repaid from free cash flow. It is a stricter measure than OCF/Debt as it accounts for capital expenditures.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Free Cash Flow to Debt Ratio's Vetanova with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Leverage — Vetanova

All Key Metrics — Vetanova